For example, there is evidence that loss of the tumor-suppressing lipid phosphatase PTEN and, thereby, induced autocrine FGF10/FGFR2 signaling may support the development of cutaneous squamous cell carcinoma (SCC) [41]. This evidence concerns the gene PTEN and cutaneous squamous cell carcinoma.